C4 Therapeutics, Inc.
CCCC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662579
No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in C4 Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 119
- +6 vs. Q3 2021
- Shares held
- 35.9M
- +1.40M (+4.1%) vs. Q3 2021
- Total value
- $1.15B
- −$387.8M (−25.1%) vs. Q3 2021
- New holders
- 22
- 42 more added
- Sold out
- 16
- 33 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CCCC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 147 | $547.6M |
| Q1 2026 | 123 | $221.3M |
| Q4 2025 | 101 | $152.5M |
| Q3 2025 | 97 | $116.6M |
| Q2 2025 | 102 | $78.2M |
| Q1 2025 | 115 | $102.6M |
| Q4 2024 | 113 | $231.8M |
| Q3 2024 | 118 | $365.9M |
| Q2 2024 | 115 | $281.3M |
| Q1 2024 | 106 | $475.6M |
| Q4 2023 | 92 | $265.6M |
| Q3 2023 | 84 | $64.5M |
| Q2 2023 | 100 | $94.1M |
| Q1 2023 | 121 | $117.5M |
| Q4 2022 | 117 | $231.4M |
| Q3 2022 | 114 | $345.9M |
| Q2 2022 | 113 | $297.2M |
| Q1 2022 | 125 | $904.8M |
| Q4 2021 | 119 | $1.15B |
| Q3 2021 | 113 | $1.54B |
| Q2 2021 | 107 | $1.21B |
| Q1 2021 | 83 | $926.8M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding C4 Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Soleus Capital Management, L.P. | 561,122 | $18.1M | 2.44% | −189,511−25.2% | Reduced |
| Laurion Capital Management LP | 581,028 | $18.7M | 0.32% | −81,435−12.3% | Reduced |
| FMR LLC | 648,981 | $20.9M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 686,176 | $22.1M | 0.00% | +19,853+3.0% | Added |
| Millennium Management LLC | 753,391 | $24.3M | 0.03% | +465,818+162.0% | Added |
| Morgan Stanley | 918,470 | $29.6M | 0.00% | +628,374+216.6% | Added |
| Adage Capital Partners GP, L.L.C. | 996,477 | $32.1M | 0.06% | +185,000+22.8% | Added |
| Janus Henderson Group PLC | 1,045,945 | $33.7M | 0.01% | −2,943−0.3% | Reduced |
| Pictet Asset Management SA | 1,060,628 | $34.2M | 0.03% | −37,793−3.4% | Reduced |
| Wasatch Advisors Inc | 1,295,462 | $41.7M | 0.17% | −46,585−3.5% | Reduced |
| Ra Capital Management, L.P. | 1,377,569 | $44.4M | 0.78% | 00.0% | Unchanged |
| State Street Corp | 1,589,753 | $51.2M | 0.00% | −68,877−4.2% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $52.9M | 4.19% | +10.0% | Added |
| ArrowMark Colorado Holdings LLC | 1,774,504 | $57.1M | 0.46% | +259,884+17.2% | Added |
| Vanguard Group Inc | 2,016,459 | $64.9M | 0.00% | +77,884+4.0% | Added |
| Perceptive Advisors LLC | 2,208,913 | $71.1M | 1.10% | −49,653−2.2% | Reduced |
| RTW Investments, LP | 2,494,965 | $80.3M | 1.17% | 00.0% | Unchanged |
| BlackRock Inc. | 3,405,982 | $109.7M | 0.00% | +248,775+7.9% | Added |
| Price T Rowe Associates Inc | 4,084,798 | $131.5M | 0.01% | +127,055+3.2% | Added |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −86,952−100.0% | Sold out |
| P.A.W. Capital Corp | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −39,506−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −23,270−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −21,073−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −21,000−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −6,719−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −6,423−100.0% | Sold out |
| Meristem Family Wealth, LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −5,056−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −1,037−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |